Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Area Under Trough Concentrations of Tacrolimus as a Predictor of Progressive Renal Impairment After Liver Transplantation.
Rodríguez-Perálvarez M, Guerrero M, De Luca L, Gros B, Thorburn D, Patch D, Aumente MD, Westbrook R, Fernández R, Amado V, Aguilar P, Montero JL, O'Beirne J, Briceño J, Tsochatzis E, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: de luca l, de la mata m. Transplantation. 2019 Dec;103(12):2539-2548. doi: 10.1097/TP.0000000000002760. Transplantation. 2019. PMID: 31107827
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.
Parisi I, Tsochatzis E, Wijewantha H, Rodríguez-Perálvarez M, De Luca L, Manousou P, Fatourou E, Pieri G, Papastergiou V, Davies N, Yu D, Luong T, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK. Parisi I, et al. Among authors: de luca l. Liver Transpl. 2014 Nov;20(11):1327-35. doi: 10.1002/lt.23969. Liver Transpl. 2014. PMID: 25088400 Free article. Clinical Trial.
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Donati B, Pietrelli A, Pingitore P, Dongiovanni P, Caddeo A, Walker L, Baselli G, Pelusi S, Rosso C, Vanni E, Daly A, Mancina RM, Grieco A, Miele L, Grimaudo S, Craxi A, Petta S, De Luca L, Maier S, Soardo G, Bugianesi E, Colli F, Romagnoli R, Anstee QM, Reeves HL, Fracanzani AL, Fargion S, Romeo S, Valenti L. Donati B, et al. Among authors: de luca l. Cancer Med. 2017 Aug;6(8):1930-1940. doi: 10.1002/cam4.1078. Epub 2017 Jul 4. Cancer Med. 2017. PMID: 28677271 Free PMC article.
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial.
Popolo Rubbio A, Testa L, Pivato CA, Regazzoli D, Piccolo R, Esposito G, Musto C, Scalia L, Pacchioni A, Briguori C, Lucisano L, De Luca L, Conrotto F, Tartaglia F, Latini AC, Stankowski K, Chiarito M, Sardella G, Indolfi C, Bedogni F, Reimers B, Condorelli G, Stefanini GG. Popolo Rubbio A, et al. Among authors: de luca l. Cardiovasc Revasc Med. 2024 Apr 16:S1553-8389(24)00174-X. doi: 10.1016/j.carrev.2024.04.022. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38702260
Electronic Effects in a Green Protocol for (Hetero)Aryl-S Coupling.
Carraro M, Are C, Azzena U, De Luca L, Gaspa S, Satta G, Holzer W, Pace V, Pisano L. Carraro M, et al. Among authors: de luca l. Molecules. 2024 Apr 10;29(8):1714. doi: 10.3390/molecules29081714. Molecules. 2024. PMID: 38675533 Free PMC article.
1,265 results